Stocks In Focus: GERN, CRL, SHOO, DIS
Friday, July 30, 2021 8:21 AM

Related Stories



Geron Corp. (NASDAQ: GERN) announced Friday that the U.S. Food and Drug Administration has notified the company that the clinical hold placed on Geron's Investigational New Drug application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed. The FDA notification enables Geron to move forward with the world’s first clinical trial of a human embryonic stem cell-based therapy in man. Shares of Geron Corp. soared more than 12% in pre-market trading.

Charles River Laboratories International, Inc. (NYSE: CRL) said Friday that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. (NYSE: WX) to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program. Shares of Charles River Laboratories rallied more than 6% in pre-market trading.

Standard & Poor's said Friday that Steven Madden Ltd. (NASDAQ: SHOO) will replace inVentiv Health Inc. (NASDAQ: VTIV) in the S&P SmallCap 600 index after the close of trading on a date to be announced. inVentiv Health is being acquired by affiliates of Thomas H. Lee Partners in a transaction expected to be completed soon.

The Walt Disney Company (NYSE: DIS) announced Friday that it has agreed to sell its Miramax Films business to Filmyard Holdings for over $660 million.

Disclosure: Author doesn't own any of the stocks discussed here.

 

Sponsors

Symbol :

Advertisement

Market news:

More news


Advertisement

    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
XXXXXXXXXX HOGS$0.35
XXXXXXXXXX AGNC$1.16
XXXXXXXXXX LVS$0.08
XXXXXXXXXX SNDK$0.87
XXXXXXXXXX APKT$0.13
XXXXXXXXXX CRUS$0.26
XXXXXXXXXX LCC$1.18
XXXXXXXXXX BAC$0.24
robertbig j JPM$0.71
XXXXXXXXXX GOOG$5.78